175 related articles for article (PubMed ID: 24434384)
1. The effect of treatment with N-acetylcysteine on the serum levels of C-reactive protein and interleukin-6 in patients on hemodialysis.
Saddadi F; Alatab S; Pasha F; Ganji MR; Soleimanian T
Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):66-72. PubMed ID: 24434384
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis.
Filiopoulos V; Hadjiyannakos D; Takouli L; Metaxaki P; Sideris V; Vlassopoulos D
Int J Artif Organs; 2009 Dec; 32(12):872-82. PubMed ID: 20037892
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study.
Nascimento MM; Suliman ME; Silva M; Chinaglia T; Marchioro J; Hayashi SY; Riella MC; Lindholm B; Anderstam B
Perit Dial Int; 2010; 30(3):336-42. PubMed ID: 20190028
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Study to Evaluate the Effects of Oral N-Acetyl Cysteine on Inflammatory and Oxidative Stress Biomarkers in Rheumatoid Arthritis.
Hashemi G; Mirjalili M; Basiri Z; Tahamoli-Roudsari A; Kheiripour N; Shahdoust M; Ranjbar A; Mehrpooya M; Ataei S
Curr Rheumatol Rev; 2019; 15(3):246-253. PubMed ID: 30255760
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease.
Ahbap E; Sakaci T; Kara E; Sahutoglu T; Koc Y; Basturk T; Sevinc M; Akgol C; Kayalar AO; Ucar ZA; Bayraktar F; Unsal A
Clin Nephrol; 2016 Apr; 85(4):199-208. PubMed ID: 26521887
[TBL] [Abstract][Full Text] [Related]
7. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels.
Borazan A; Ustün H; Ustundag Y; Aydemir S; Bayraktaroglu T; Sert M; Yilmaz A
Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612
[TBL] [Abstract][Full Text] [Related]
8. Effect of statins on chronic inflammation and nutrition status in renal dialysis patients: a systematic review and meta-analysis.
Deng J; Wu Q; Liao Y; Huo D; Yang Z
Nephrology (Carlton); 2012 Aug; 17(6):545-51. PubMed ID: 22429568
[TBL] [Abstract][Full Text] [Related]
9. Effect of anti-HCV positivity on markers of malnutrition and inflammation in hemodialysis patients.
Zumrutdal A; Ozer B; Singan M; Micozkadioglu H; Sezer S; Ozdemir FN; Haberal M
Ren Fail; 2007; 29(1):85-90. PubMed ID: 17365915
[TBL] [Abstract][Full Text] [Related]
10. Intravenous N-acetylcysteine during hemodialysis reduces asymmetric dimethylarginine level in end-stage renal disease patients.
Thaha M; Widodo ; Pranawa W; Yogiantoro M; Tomino Y
Clin Nephrol; 2008 Jan; 69(1):24-32. PubMed ID: 18226399
[TBL] [Abstract][Full Text] [Related]
11. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral N-acetylcysteine treatment on immune system in continuous ambulatory peritoneal dialysis patients.
Purwanto B; Prasetyo DH
Acta Med Indones; 2012 Apr; 44(2):140-4. PubMed ID: 22745145
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis.
Zhang W; He J; Zhang F; Huang C; Wu Y; Han Y; Zhang W; Zhao Y
J Nephrol; 2013; 26(2):243-53. PubMed ID: 22684644
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes in patients with end-stage renal disease is not associated with further increased serum inflammatory parameters.
Bodlaj G; Berg J; Pichler R; Sailer T; Biesenbach G
J Nephrol; 2004; 17(1):112-7. PubMed ID: 15151267
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory effects of rosuvastatin treatment on coronary artery ectasia patients of different age groups.
Fan CH; Hao Y; Liu YH; Li XL; Huang ZH; Luo Y; Li RL
BMC Cardiovasc Disord; 2020 Jul; 20(1):330. PubMed ID: 32652935
[TBL] [Abstract][Full Text] [Related]
17. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD.
Honda H; Qureshi AR; Heimbürger O; Barany P; Wang K; Pecoits-Filho R; Stenvinkel P; Lindholm B
Am J Kidney Dis; 2006 Jan; 47(1):139-48. PubMed ID: 16377395
[TBL] [Abstract][Full Text] [Related]
18. Dialysis modality and nutritional status are associated with variability of inflammatory markers.
Snaedal S; Qureshi AR; Lund SH; Germanis G; Hylander B; Heimbürger O; Carrero JJ; Stenvinkel P; Bárány P
Nephrol Dial Transplant; 2016 Aug; 31(8):1320-7. PubMed ID: 27220753
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between inflammation,coagulation/fibrinolysis and vascular access in hemodialysis patients.
Costa E; Rocha S; Rocha-Pereira P; Castro E; Reis F; Teixeira F; Miranda V; Do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
J Vasc Access; 2008; 9(4):248-53. PubMed ID: 19085894
[TBL] [Abstract][Full Text] [Related]
20. Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress.
Pupim LB; Himmelfarb J; McMonagle E; Shyr Y; Ikizler TA
Kidney Int; 2004 Jun; 65(6):2371-9. PubMed ID: 15149350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
